NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054666

Registered date:14/06/2024

Clinical Validation Study of Plasma-based BRAF Gene Mutation Testing using LS104R in Metastatic Colorectal Cancer

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedColorectal cancer
Date of first enrollment2023/06/09
Target sample size113
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeSensitivity and specificity of Test method compared to Reference method for the detection of BRAF V600E mutation.
Secondary Outcome-Diagnostic accuracy of Test method compared to Reference method. -Positive predictive value (PPV) and negative predictive value (NPV) of Test method compared to Reference method.

Key inclusion & exclusion criteria

Age minimum18years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria-Patients judged ineligible to participate in the study -Patients previously enrolled in this study -Patients with history of multiple cancer or with a comorbid multiple cancer -Patients with synchronous or metachronous (within 5 years of disease-free interval) double cancer

Related Information

Contact

public contact
Name Masahiro Nishida
Address 4-4-4 Takatsukadai, Nishi-ku, Kobe 651-2271, Japan Japan 651-2271
Telephone 078-991-1911
E-mail Nishida.Masahiro@sysmex.co.jp
Affiliation Sysmex Corporation Medical & Scientific Affairs
scientific contact
Name Takayuki Yoshino
Address 6-5-1, Kashiwanoha, Kashiwa, Chiba, 277-8577 Japan Japan
Telephone 04-7133-1111
E-mail tyoshino@east.ncc.go.jp
Affiliation National Cancer Center Hospital East Department of Gastroenterology and Gastrointestinal Oncology